Coordinator Medical Assistant
Resume:
CURRICULUM VITAE
Robin D. Bowman, BS, CMA (AAMA)
Jamestown, NC 27282
********@*******.***
EDUCATION YEARS DEGREE/DIPLOMA
Appalachian State University 2009-2013 Bachelor of
Science
Boone, North Carolina Psychology,
Sociology
Wilkes Community College 2007-2009 Associate of Arts
Wilkesboro, North Carolina
Wilkes Community College 2002- 2004
Associate of Applied
Wilkesboro, North Carolina Science, Medical
Assistant
Certification: Medical Assistant North Carolina March 2014-
Present #2385923
May 2004-March 2007
EXPERIENCE YEARS LOCATION
PharmQuest 2013-Present Greensboro, North
Carolina
Research Coordinator
Mountain Top Clinical Research 2003-2007 Sparta, North
Carolina
Research Coordinator
SHARE Clinic 2004-2006 Sparta, North Carolina
Certified Medical Assistant
JOB DUTIES / ROLES
. Maintains submission of regulatory documents to sponsors for IRB
approval.
. Performs responsibilities with minimal support from management.
. Implements proper informed consent procedures, compliance with
protocol, GCP/ICH Guidelines and other applicable regulatory
requirements, and assurance of good site performance.
. Performs detailed review of subject records, essential documents,
investigational product disposition and accountability, site personnel
and procedures.
. Performs safety reporting of AEs and SAEs immediately to PI and
Sponsor.
. Maintains prompt attention of data entry, data locks and resolving
queries in a timely fashion.
. Reports all significant issues to appropriate personnel immediately.
. Participates in company-required training programs.
. Performs necessary functions (e.g., creation of source documents,
processing and shipment of labs, and performing ECGs per protocol
requirements).
. Maintains office (e.g., properly securing medical records and
Regulatory Binders).
. Performs other duties as assigned
SOFTWARE EXPERIENCE
. InForm 4.5, 5.5
. Cenduit
. WriteResult
. eTarget
. MyTrails
. ePresentOnline
. ClinTrak
. eClinical OS
. ERT
. iMedidata
. ACE
. Microsoft Office
CLINICAL RESEARCH
Coordinator, "A Multicenter, Randomized, Double-Blind, Placebo-Controlled,
Phase 3 Trial to Evaluate the Efficacy and Safety of BMS-XXXX) as
Monotherapy in Subjects with Type 2 Diabetes Who Have Inadequate Glycemic
Control with Diet and Exercise" (Bristol Myers Squibb - Phase III)
Coordinator, "A Multicenter, Randomized, Double-Blind, Placebo Controlled,
Phase 3 Trial to Evaluate the Efficacy and Safety of (BMS-XXXX) In
Combination with Thiazolidinedione Therapy in Subjects with Type 2 Diabetes
Who Have Inadequate Glycemic Control on Thiazolidinedione Therapy Alone"
(Bristol Myers Squibb - Phase III)
Coordinator, "A Multicenter, Randomized, Double-Blind, Placebo-Controlled,
Phase 3 Trial to Evaluate the Efficacy and Safety of (BMS-XXXX) in
Combination with Metformin in Subjects with Type 2 Diabetes Who Have
Inadequate Glycemic Control on Metformin Alone" (Bristol Myers Squibb -
Phase III)
Coordinator, "A Randomized, Double-Blind, Parallel Group, Multicenter Study
to Evaluate the Efficacy and Safety of ETC-XXXX, and the Combination
in Hypercholesterolemic Patients With or Without Statin Toleranc" (Esperion
- Phase II)
Coordinator, "Pharmacokinetic Evaluations of following Subcutaneous
Administration Using Prefilled Syringe or Auto-Injector in Patients with
Moderate-to-Severe Plaque Psoriasis" - (Lilly - Phase III)
Coordinator, "A Comparsion of versus Human Insulin NPH as Basal
Insulin Treatment in Insulin-Naive Patients with Type 2 Diabetes Mellitus
not Adequately Controlled with 2 or more Oral Antihyperglycemic
Medications: An Open-Label, Randomized Study" (Lilly - Phase IIIa)
Coordinator, "Double blind and Open Label 2 year extension of subq in
prefilled syringes assessing long term safety, tolerability & efficacy in
subjects with moderate to severe chronic plaque-type psoriasis treated with
either a fixed dose regimen or on a retreatment at start of relapse
regimen" (Novartis - Phase III)
Coordinator, "A Multicenter, Randomized, Double-Blind, Double-Dummy,
Placebo-Controlled, Parallel Group, Multi-dose Study Comparing the Efficacy
and Safety of Subcutaneous with Placebo for the Preventive Treatment
of Chronic Migraine" (Labry's - Phase IIa)
Coordinator, "A phase lll, randomized, open-label, active-controlled,
multicenter trial to study the contraceptive efficacy & safety of the
commercial batch of oral tablets of MK-XXXX (nomegestrol acetate-17B-
estradiol) in healthy, sexually-active women aged 18-50 years" (Merck -
Phase III)
Coordinator, "A 4-week, Randomized, Placebo-Controlled, Double Blind,
Efficacy and Safety Study of in Adults with Primary
Hypercholesterolemia" (Zhejiang Hisun - Phase IIa)
Coordinator, "A Multicenter, Randomized, Double-Blind, Placebo-Controlled,
Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of
Subcutaneous with Placebo for the Preventive Treatment of High
Frequency Episodic Migraine" (Labry's - Phase IIa)
Coordinator, "A Phase 3, Randomized, Double-blind, Active Controlled,
Multicenter Trial to Evaluate the Safety and Efficacy of Compared to
Pioglitazone in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic
Control" (Bristol Myers Squibb - Phase III)
Coordinator, "A Phase 3, Randomized, Three-Arm, Double-blind, Active
Controlled, Parallel Group, Multicenter Trial to Evaluate the Safety and
Efficacy of in Combination With Metformin Compared to Glimepiride in
Combination With Metformin in Subjects Wtih Type 2 Diabetes Who Have
Inadequate Glycemic Control on Metformin Therapy Alone" (Bristol Myers
Squibb - Phase III)
Coordinator, "Multicenter Assessment of Transdermal Therapy in Overactive
Bladder With TDS (XXXX)" (Watson - Phase IV)
Coordinator, "A Multicenter, Randomized, Double-Blind, Placebo-Controlled,
Phase III Trial to Evaluate the Efficacy and Safety of in Combination
With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate
Glycemic Control on Metformin Alone" (Bristol Myers Squibb - Phase III)
Coordinator, "A Multicenter, Randomized, Double-Blind Placebo-Controlled
Phase 3 Trial to Evaluate the Efficacy and Safety of in Combination
With Glyburide in Subjects With Type 2 Diabetes Who Have Inadequate
Glycemic Control With Glyburide Alone" (Bristol Myers Squibb - Phase III)
Coordinator, "A Single-center,Double-blind,Randomised,Placebo-
controlled,Parallel-group Study to Assess the Effect of 24 Weeks of
Treatment With V on Insulin Sensitivity and Its Underlying Mechanism
in Patients With T2DM Treated With Metformin" (Novartis - Phase III)
Coordinator, "A Phase 2, Double-Blind Randomized, Placebo-Controlled,
Parallel Group, Multicenter Study to Evaluate Treatment With in
Subjects With Type 2 Diabetes" (Takeda - Phase II)
Coordinator, "A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study
to Determine the Efficacy, Safety, and Tolerability of in the
Treatment of Subjects With Type 2 Diabetes" (Takeda - Phase III)
Coordinator, "A Phase 2, Double-Blind, Randomized, Placebo-Controlled,
Parallel-Group, Multicenter Study to Evaluate Treatment With in
Subjects With Type 2 Diabetes" (Takeda - Phase II)
Coordinator, "A Phase 2b, Randomized, Double-Blind, Placebo-Controlled
Study of in Patients with Episodic Migraine" (Lilly - Phase 2b)
Coordinator, "A Phase 4, Randomized, Double-Blind Trial to Evaluate the
Immunogenicity and Safety of a XX Pneumococcal Vaccine When
Administered Concomitantly With Seasonal Inactivated Influenza Vaccine in
Adults 50 Years and Older Who Received 1 or More Doses OF 23-VALENT
Pneumococcal Polysaccharide Vaccine Prior to Study Enrollment" (Pfizer -
Phase IV)
Contact this candidate